BERKELEY, Calif.–(BUSINESS WIRE)–Newomics Inc., a biotechnology company developing and commercializing mass spectrometry solutions, today announced that it has established a North America Sales Team, and it is launching a new product to enhance the existing mass spectrometry workflows. Newomics continues its dedication to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. The MnESI platform (M3 multinozzle emitter + MnESI sour
Leave Comment